![]() |
<< Back |
First Quarter Fiscal Year 2024 Highlights
-
Quarterly net sales of
$459.3 million -
Quarterly net income of
$926,000 or$0.02 per basic and diluted common share - Net average selling price for specialty eggs increased 8.4 percent quarter-over-quarter
-
Cash dividend of
$294,000 , or$0.006 per share, pursuant to the Company’s established dividend policy
Overview
“Our operations ran well during the quarter, and we benefitted from lower feed costs, although we generally continued to incur higher input costs. Our team has continued to focus on managing our operations in an efficient and sustainable manner. While there have been no recent outbreaks of HPAI in commercial egg laying flocks, we remain diligent in following strict protocols and continue to invest in additional resources to reduce future risk. We commend the work of our managers and employees who responsibly managed our production and continued to bring more quality eggs to the market to support our valued customers. We also have a number of expansion projects underway to increase our production capacity, and we look forward to the opportunities to expand our market reach.
“In addition to our organic growth initiatives, we have continued to expand our business through selective acquisitions. Following the end of the first quarter, we announced a definitive agreement to acquire substantially all the assets of
Sales Performance & Operating Highlights
“Conventional egg net average selling price per dozen was
“We reported an operating loss of
“Current indications for corn project an overall better stocks-to-use ratio; however, until this year’s harvest is complete and as long as outside factors remain uncertain [including weather patterns and the
|
13 Weeks Ended |
||||||
|
|
|
|
||||
Dozen Eggs Sold (000) |
|
273,126 |
|
|
|
275,317 |
|
Conventional Dozen Eggs Sold (000) |
|
181,530 |
|
|
|
179,712 |
|
Specialty Dozen Eggs Sold (000) |
|
91,596 |
|
|
|
95,605 |
|
Dozen Eggs Produced (000) |
|
250,356 |
|
|
|
257,654 |
|
% Specialty Sales (dozen) |
|
33.5 |
% |
|
|
34.7 |
% |
% Specialty Sales (dollars) |
|
47.7 |
% |
|
|
31.8 |
% |
Net Average Selling Price (per dozen) |
$ |
1.589 |
|
|
$ |
2.275 |
|
Net Average Selling Price Conventional Eggs (per dozen) |
$ |
1.241 |
|
|
$ |
2.368 |
|
Net Average Selling Price Specialty Eggs (per dozen) |
$ |
2.278 |
|
|
$ |
2.101 |
|
Feed Cost (per dozen) |
$ |
0.597 |
|
|
$ |
0.667 |
|
Product Mix & Cage-Free Eggs
“Specialty eggs remain an important area of focus of Cal-Maine Food’s growth strategy. A top priority of this strategy is to expand our cage-free production capacity with the goal of meeting future customer needs in line with changing state requirements. We continue to work closely with our customers regarding their expected timing and purchase decisions related to their previously announced plans to offer cage-free eggs exclusively by specific future dates. We have invested significant capital to acquire and construct cage-free facilities as our volume of cage-free egg sales has continued to increase and account for a greater share of our product mix. Cage-free egg revenue comprised approximately 33.0% of total net shell egg revenue for the first quarter of fiscal 2024,” added Bowman.
Table Egg Supply Outlook
The most recent outbreak of HPAI affected the Company’s business and financial results primarily during the fourth quarter of fiscal 2022 and continuing into the first part of the fourth quarter of fiscal 2023. While the last occurrence in a commercial egg laying flock was in
Layer hen numbers reported by the
Looking Ahead
Miller added, “We look forward to the opportunities ahead for
Dividend Payment
For the first quarter of fiscal 2024,
About
Forward Looking Statements
Statements contained in this press release that are not historical facts are forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. The forward-looking statements are based on management’s current intent, belief, expectations, estimates and projections regarding our company and our industry. These statements are not guarantees of future performance and involve risks, uncertainties, assumptions and other factors that are difficult to predict and may be beyond our control. The factors that could cause actual results to differ materially from those projected in the forward-looking statements include, among others, (i) the risk factors set forth in the Company’s
FINANCIAL HIGHLIGHTS (Unaudited) (In thousands, except per share amounts)
SUMMARY STATEMENTS OF INCOME
|
||||||||
|
|
13 Weeks Ended |
||||||
|
|
|
|
|
||||
Net sales |
|
$ |
459,344 |
|
|
$ |
658,344 |
|
Cost of sales |
|
|
413,911 |
|
|
|
440,854 |
|
Gross profit |
|
|
45,433 |
|
|
|
217,490 |
|
Selling, general and administrative |
|
|
52,246 |
|
|
|
53,607 |
|
(Gain) loss on disposal of fixed assets |
|
|
(56 |
) |
|
|
33 |
|
Operating income (loss) |
|
|
(6,757 |
) |
|
|
163,850 |
|
Other income, net |
|
|
7,490 |
|
|
|
1,630 |
|
Income before income taxes |
|
|
733 |
|
|
|
165,480 |
|
Income tax expense |
|
|
322 |
|
|
|
40,346 |
|
Net income |
|
|
411 |
|
|
|
125,134 |
|
Less: Loss attributable to noncontrolling interest |
|
|
(515 |
) |
|
|
(153 |
) |
Net income attributable to |
|
$ |
926 |
|
|
$ |
125,287 |
|
|
|
|
|
|
|
|
||
Net income per common share: |
|
|
|
|
|
|
||
Basic |
|
$ |
0.02 |
|
|
$ |
2.58 |
|
Diluted |
|
$ |
0.02 |
|
|
$ |
2.57 |
|
Weighted average shares outstanding: |
|
|
|
|
|
|
||
Basic |
|
|
48,690 |
|
|
|
48,623 |
|
Diluted |
|
|
48,840 |
|
|
|
48,811 |
|
|
|
|
|
|
|
|
FINANCIAL HIGHLIGHTS (Unaudited) (In thousands)
SUMMARY BALANCE SHEETS
|
||||||
|
|
|
|
|
||
ASSETS |
|
|
|
|
|
|
Cash and short-term investments |
|
$ |
609,962 |
|
$ |
647,914 |
Receivables, net |
|
|
159,150 |
|
|
187,213 |
Inventories, net |
|
|
280,801 |
|
|
284,418 |
Prepaid expenses and other current assets |
|
|
14,145 |
|
|
5,380 |
Current assets |
|
|
1,064,058 |
|
|
1,124,925 |
|
|
|
|
|
|
|
Property, plant and equipment, net |
|
|
752,580 |
|
|
744,540 |
Other noncurrent assets |
|
|
83,729 |
|
|
85,060 |
Total assets |
|
$ |
1,900,367 |
|
$ |
1,954,525 |
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS' EQUITY |
|
|
|
|
|
|
Accounts payable and accrued expenses |
|
$ |
126,088 |
|
$ |
145,601 |
Dividends payable |
|
|
294 |
|
|
37,130 |
Current liabilities |
|
|
126,382 |
|
|
182,731 |
|
|
|
|
|
|
|
Deferred income taxes and other liabilities |
|
|
162,655 |
|
|
162,211 |
Stockholders' equity |
|
|
1,611,330 |
|
|
1,609,583 |
Total liabilities and stockholders' equity |
|
$ |
1,900,367 |
|
$ |
1,954,525 |
View source version on businesswire.com: https://www.businesswire.com/news/home/20231003159352/en/
(601) 948-6813
Source: